Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2587
Abstract: To describe the baseline characteristics of participants in the Acetazolamide in Decompensated Heart Failure with Volume Overload (ADVOR) trial and compare these with other contemporary diuretic trials in acute heart failure (AHF). read more here.
Keywords: heart failure; baseline characteristics; decompensated heart; acetazolamide decompensated ... See more keywords